Life Science Company News

Global Hemoglobin Testing Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

DUBLIN, May 13, 2021 /PRNewswire/ -- The "Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global hemoglobin testing market exhibited moderate growth during 2015-2020. A hemoglobin test measures the count of red blood cells (RBC) or the level of hemoglobin in the blood. Hemoglobin is a type of protein present in the RBCs that carries oxygen to the organs and transports carbon dioxide back to the lungs. Hemoglobin tests are used extensively by doctors as a part of their routine check-ups or to diagnose a serious medical condition in the patient. If a test reveals that the hemoglobin level in an individual's body is lower than normal, it means that they have a low RBC count and are prone to disorders such as anemia. If the RBC count is higher than normal, it could be an indication for a blood disorder or can be caused by living at a high altitude, smoking and dehydration. The key end users of hemoglobin testing market are medical laboratories, hospitals and research centers.



An increasing prevalence of chronic disorders such as anemia and diabetes represent a key factor driving the global hemoglobulin testing market. In 2018, an estimated 490 Million people around the world suffered from diabetes. The prevalence of diabetes is currently being catalysed by an increasing ageing population, poor dietary habits, sedentary lifestyles and rising levels of obesity. Patients suffering from diabetes need to undergo tests to measure blood glucose and HbA1c levels regularly, driving the demand for such tests. Moreover, factors such as favourable reimbursement of hemoglobin testing under various health insurance policies is also catalyzing the growth of the market.

However, in many countries, medical insurance doesn't fully reimburse the cost of hemoglobin testing, but with partial payment and other coverages, consumers are increasingly adopting regular and periodic tests in order to check and maintain their overall health. Furthermore, factors such as improving health infrastructure, increasing per capita expenditure on health care, rising awareness for blood-related ailments, ageing population, technological advancements, etc. are also projected to drive the global hemoglobin testing market in the coming years. Looking forward, the publisher expects the global hemoglobin testing market to grow at a CAGR of 6.80% during 2021-2026.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Alere, ACON Laboratories, ARKRAY, Bayer Medical Care, Daiichi Biotech, DiaSys Diagnostic Systems, Epinex Diagnostics, Erba Diagnostics, etc

Key Questions Answered in This Report:

  • How has the global hemoglobin testing market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global hemoglobin testing industry?
  • What has been the impact of COVID-19 on the global hemoglobin testing industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global hemoglobin testing industry?
  • What are the key driving factors and challenges in the global hemoglobin testing industry?
  • What is the structure of the global hemoglobin testing industry and who are the key players?
  • What is the degree of competition in the global hemoglobin testing industry?
  • What are the profit margins in the global hemoglobin testing industry?

Key Topics Covered:



1 Preface



2 Scope and Methodology



3 Executive Summary



4 Introduction

4.1 Overview

4.2 Key Industry Trends



5 Global Hemoglobin Testing Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Breakup by Product Type

5.5 Market Breakup by Technology

5.6 Market Breakup by End-User

5.7 Market Breakup by Region

5.8 Market Forecast



6 Market Breakup by Product Type

6.1 Reagents and Consumables

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Equipment

6.2.1 Market Trends

6.2.2 Market Forecast



7 Market Breakup by Technology

7.1 Chromatography

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Immunoassay

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Others

7.3.1 Market Trends

7.3.2 Market Forecast



8 Market Breakup by End-User

8.1 Laboratories

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Hospitals

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Research centers

8.3.1 Market Trends

8.3.2 Market Forecast



9 Market Breakup by Region

9.1 Europe

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 North America

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Asia Pacific

9.3.1 Market Trends

9.3.2 Market Forecast

9.4 Middle East and Africa

9.4.1 Market Trends

9.4.2 Market Forecast

9.5 Latin America

9.5.1 Market Trends

9.5.2 Market Forecast



10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats



11 Value Chain Analysis



12 Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes



13 Price Analysis



14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 Abbott

14.3.2 Bio-Rad Laboratories

14.3.3 Danaher

14.3.4 EKF Diagnostics

14.3.5 F. Hoffmann-La Roche

14.3.6 Siemens Healthineers

14.3.7 Thermo Fisher Scientific

14.3.8 Alere

14.3.9 ACON Laboratories

14.3.10 ARKRAY

14.3.11 Bayer Medical Care

14.3.12 Daiichi Biotech

14.3.13 DiaSys Diagnostic Systems

14.3.14 Epinex Diagnostics

14.3.15 Erba Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/5stfui

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com



For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-hemoglobin-testing-market-2021-to-2026---industry-trends-share-size-growth-opportunity-and-forecasts-301290864.html

SOURCE Research and Markets

By: PR Newswire Association LLC. - 13 May 2021
Back to overview

Enhance your business development with Biotechgate